Overview ARIXTRA Local Study For Registration In China. Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary This is a local registration study in China to compare the safety and efficacy of ARIXTRA to Enoxaparine in patients undergoing elective major hip or knee replacement or a revision of components. Phase: Phase 3 Details Lead Sponsor: GlaxoSmithKlineTreatments: EnoxaparinFondaparinuxPENTA